Mason Katie L, Huffnagle Gary B
Pulmonary Division, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Cell Microbiol. 2009 Sep;11(9):1297-305. doi: 10.1111/j.1462-5822.2009.01347.x. Epub 2009 Jun 25.
The gastrointestinal tract carries out the complex process of localizing the polymicrobial populations of the indigenous microbiota to the lumenal side of the GI mucosa while absorbing nutrients from the lumen and preventing damage to the mucosa. This process is accomplished through a combination of physical, innate and adaptive host defences and a 'strategic alliance' with members of the microbiota. To cope with the constant exposure to a diverse microbial community, the GI tract, through the actions of a number of specialized cells in the epithelium and lamina propria, has layers of humoral, physical and cellular defences that limit attachment, invasion and dissemination of the indigenous microbiota. However, the role of the microbiota in this dynamic balance is vital and serves as another level of 'innate' defence. We are just beginning to understand how bacterial metabolites aid in the control of potential pathogens within the microbiota and limit inflammatory responses to the microbiota, concepts that will impact our understanding of the biological effects of antibiotics, diet and probiotics on mucosal inflammatory responses.
胃肠道执行着一个复杂的过程,即将本地微生物群的多种微生物群体定位到胃肠道黏膜的管腔侧,同时从管腔吸收营养并防止黏膜受损。这个过程是通过物理、固有和适应性宿主防御以及与微生物群成员的“战略联盟”共同完成的。为了应对持续接触多样的微生物群落,胃肠道通过上皮和固有层中一些特化细胞的作用,拥有体液、物理和细胞防御层,这些防御层限制了本地微生物群的附着、侵袭和扩散。然而,微生物群在这种动态平衡中的作用至关重要,它是“固有”防御的另一个层面。我们才刚刚开始了解细菌代谢产物如何有助于控制微生物群内的潜在病原体,并限制对微生物群的炎症反应,这些概念将影响我们对抗生素、饮食和益生菌对黏膜炎症反应的生物学效应的理解。